Invention Grant
- Patent Title: RGD and transferrin nanoparticle composition
-
Application No.: US16087557Application Date: 2017-03-23
-
Publication No.: US10765637B2Publication Date: 2020-09-08
- Inventor: Toru Maekawa , Sakthikumar Dasappan Nair , Sheikh Mohamed Mohamed , Srivani Veeranarayanan
- Applicant: TOYO UNIVERSITY
- Applicant Address: JP Tokyo
- Assignee: TOYO UNIVERSITY
- Current Assignee: TOYO UNIVERSITY
- Current Assignee Address: JP Tokyo
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@45c64c1
- International Application: PCT/JP2017/011834 WO 20170323
- International Announcement: WO2017/164331 WO 20170928
- Main IPC: A61K9/51
- IPC: A61K9/51 ; A61K47/10 ; A61K47/12 ; A61K47/24 ; A61K47/42 ; A61K49/00 ; A61K9/16 ; A61K45/00 ; A61P35/00 ; A61K38/16 ; B82Y5/00

Abstract:
Provided is a composition which can be utilized for drug delivery systems that can penetrate the blood brain barrier, and has low cytotoxicity. A nanoparticle composition comprises nanoparticles to the surface of which a first substance and a second substance each having specificity to a tumor cell are bound, wherein the first substance having specificity to the tumor cell is a peptide comprising an amino acid sequence of arginine-glycine-aspartic acid, and wherein the second substance having specificity to the tumor cell is an iron-binding protein, and wherein the nanoparticles each comprise an outer layer and vesicles enveloped by the outer layer and the nanoparticles each comprise, as membrane components, a PEGylated phospholipid, a fatty acid with a melting point of 30° C. or more, and a non-PEGylated phospholipid.
Public/Granted literature
- US20190099382A1 DRUG DELIVERY NANOPARTICLE COMPOSITION Public/Granted day:2019-04-04
Information query